SuperworthLemaitre Vascular EPS LMAT
Diluted earnings per share by quarter and over the last twelve months, from 2010.
- Last 12 months, to Jun 30, 2026
- $2.85
- Latest quarter, Q2 FY26
- $0.74
- +23% on a year earlier
- Fiscal year 2025
- $2.51
- +29% on the year before
Lemaitre Vascular's earnings per share was $2.85 over the twelve months to Jun 30, 2026, up 38% on a year earlier.
In its latest quarter, Q2 FY26, it was $0.74, up 23% on the same quarter a year before.
Over the five fiscal years to FY2025 it grew 19% a year on average.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | $2.51 | +29% |
| FY2024 | $1.94 | +45% |
| FY2023 | $1.34 | +44% |
| FY2022 | $0.93 | −26% |
| FY2021 | $1.26 | +21% |
| FY2020 | $1.04 | +18% |
| FY2019 | $0.88 | −22% |
| FY2018 | $1.13 | +33% |
| FY2017 | $0.85 | +55% |
| FY2016 | $0.55 | +31% |
| FY2015 | $0.42 | +83% |
| FY2014 | $0.23 | +10% |
| FY2013 | $0.21 | +40% |
| FY2012 | $0.15 | +15% |
| FY2011 | $0.13 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | $0.74 | +23% | $2.85 | |
| Q1 FY26 | $0.68 | +42% | $2.71 | |
| Q4 FY25 | $0.68 | +39% | $2.51 | |
| Q3 FY25 | $0.75 | +53% | $2.32 | |
| Q2 FY25 | $0.60 | +15% | $2.06 | |
| Q1 FY25 | $0.48 | +9% | $1.98 | |
| Q4 FY24 | $0.49 | +29% | $1.94 | |
| Q3 FY24 | $0.49 | +48% | $1.83 | |
| Q2 FY24 | $0.52 | +44% | $1.67 | |
| Q1 FY24 | $0.44 | +63% | $1.51 | |
| Q4 FY23 | $0.38 | +52% | $1.34 | |
| Q3 FY23 | $0.33 | +32% | $1.21 |
Against its peers
Companies in Medical - Instruments & Supplies nearest Lemaitre Vascular's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| LMATLemaitre Vascular | $2.85 | +38% a year |
| INSPInspire Medical Systems | $4.62 | +166% a year |
| UFPTUFP Technologies | $9.28 | +8% a year |
| EYENational Vision | $0.61 | |
| CDRECadre | $0.81 | −14% a year |
| BVSBioventus | $0.77 | |
| ATRCAtriCure | $0.21 | |
| WRBYWarby Parker | $0.07 | |
| STAAStaar Surgical | $0.07 | |
| IRMDIradimed | $1.79 | +10% a year |
| NVSTEnvista | $0.58 | +81% a year |
| Peer median | $0.69 |
Where Lemaitre Vascular ranks
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Lemaitre Vascular
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.